Peter Pfreundschuh

Directeur/Membre du Conseil chez Gitbasic LLC

Profil

Peter P.
Pfreundschuh currently works at Gitbasic LLC, as Director and Speratus Therapeutics, Inc., as Director.
Mr. Pfreundschuh also formerly worked at AstraZeneca Pharmaceuticals LP, as Executive Director-Business Development from 2007 to 2008, Reproductive Medicine Associates of New Jersey, as Director, American Standard Cos., Inc., as Principal, Immunomedics, Inc., as Chief Financial Officer & Executive VP-Finance from 2014 to 2016, Johnson & Johnson, as Principal from 1999 to 2007, Ernst & Young LLP, as Auditor, 3-Dimensional Pharmaceuticals, Inc., as Chief Financial Officer & Treasurer, CircuLite, Inc., as Chief Financial Officer from 2008 to 2013, Sucampo Pharmaceuticals LLC, as Chief Financial Officer from 2017 to 2018, Alimenterics, Inc., as Principal, UroGen Pharma Ltd., as Chief Financial & Compliance Officer, Secretary from 2018 to 2020, Frequency Therapeutics, Inc., as Chief Financial Officer from 2020 to 2022, Y-mAbs Therapeutics, Inc., as Chief Financial Officer & Treasurer from 2024 to 2025, and Voyager Therapeutics, Inc., as Chief Financial & Accounting Officer from 2022 to 2024.
Mr. Pfreundschuh received his Masters Business Admin degree in 2002 from Rider University and undergraduate degree in 1991 from Rutgers Business School.

Postes actifs de Peter Pfreundschuh

Sociétés	Poste	Début
Gitbasic LLC	Directeur/Membre du Conseil	-
Speratus Therapeutics, Inc.	Directeur/Membre du Conseil	-

Anciens postes connus de Peter Pfreundschuh

Sociétés	Poste	Fin
YMAS THER	Directeur Financier/CFO	16/09/2025
VOYAGER THERAPEUTICS, INC.	Directeur Financier/CFO	08/07/2024
KORRO BIO, INC.	Directeur Financier/CFO	31/03/2022
UROGEN PHARMA LTD.	Directeur Financier/CFO	01/10/2020
SUCAMPO PHARMACEUTICALS, INC.	Directeur Financier/CFO	01/02/2018